» Articles » PMID: 16960028

Effect of Alzheimer Caregiving Stress and Age on Frailty Markers Interleukin-6, C-reactive Protein, and D-dimer

Overview
Specialty Geriatrics
Date 2006 Sep 9
PMID 16960028
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Elevated plasma levels of interleukin (IL)-6, C-reactive protein (CRP), and D-dimer belong to the biological alterations of the "frailty syndrome," defining increased vulnerability for diseases and mortality with aging. We hypothesized that, compatible with premature frailty, chronic stress and age are related in predicting inflammation and coagulation activity in Alzheimer caregivers.

Methods: Plasma IL-6, CRP, and D-dimer levels were measured in 170 individuals (mean age 73 +/- 9 years; 116 caregivers, 54 noncaregiving controls). Demographic factors, diseases, drugs, and lifestyle variables potentially affecting inflammation and coagulation were obtained by history and adjusted for as covariates in statistical analyses.

Results: Caregivers had higher mean levels of IL-6 (1.38 +/- 1.42 vs 1.00 +/- 0.92 pg/mL, p =.032) and of D-dimer (723 +/- 530 vs 471 +/- 211 ng/mL, p <.001) than controls had. CRP levels were similar between groups (p =.44). The relationship between caregiver status and D-dimer was independent of covariates (p =.037) but affected by role overload. Age accounted for much of the relationship with IL-6. After controlling for covariates, the interaction between caregiver status and age was significant for D-dimer (beta =.20, p =.029) and of borderline significance for IL-6 (beta =.17, p =.090). Post hoc regression analyses indicated that, among caregivers, age was significantly correlated with both D-dimer (beta =.50, p <.001) and IL-6 (beta =.38, p =.001). Among controls, however, no significant relationship was observed between age and either D-dimer or IL-6.

Conclusions: The interaction between caregiving status and age for D-dimer and IL-6 suggests the possibility that older caregivers could be at risk of a more rapid transition to the frailty syndrome and clinical manifestations of cardiovascular diseases.

Citing Articles

Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress.

Gold N, Podrebarac S, White L, Marini C, Simon N, Mittelman M Psychedelic Med (New Rochelle). 2025; 1(2):87-97.

PMID: 40046728 PMC: 11658675. DOI: 10.1089/psymed.2022.0011.


The Effect of Exercise Program Interventions on Frailty, Clinical Outcomes, and Biomarkers in Older Adults: A Systematic Review.

Prommaban A, Moonkayaow S, Phinyo P, Siviroj P, Sirikul W, Lerttrakarnnon P J Clin Med. 2024; 13(21).

PMID: 39518709 PMC: 11547147. DOI: 10.3390/jcm13216570.


Caring about the family caregiver: A mentored journey building on the legacy of Janice Kiecolt-Glaser's pioneering research on caregivers' immune health.

Heffner K Compr Psychoneuroendocrinol. 2024; 20:100259.

PMID: 39219690 PMC: 11363704. DOI: 10.1016/j.cpnec.2024.100259.


Health conditions in spousal caregivers of people with dementia and their relationships with stress, caregiving experiences, and social networks: longitudinal findings from the IDEAL programme.

Sabatini S, Martyr A, Hunt A, Gamble L, Matthews F, Thom J BMC Geriatr. 2024; 24(1):171.

PMID: 38373905 PMC: 10875834. DOI: 10.1186/s12877-024-04707-w.


Understanding the health effects of caregiving stress: New directions in molecular aging.

Christian L, Wilson S, Madison A, Prakash R, Burd C, Rosko A Ageing Res Rev. 2023; 92:102096.

PMID: 37898293 PMC: 10824392. DOI: 10.1016/j.arr.2023.102096.